
Validea's Patient Investor model, based on Warren Buffett's strategy, has upgraded BRADY CORP (BRC) from a 72% to a 79% rating due to improved underlying fundamentals and stock valuation. This places BRC just below the 80% threshold that typically signals investment interest from the model, having passed all key Buffett-style criteria including earnings predictability, debt service, return on equity, and free cash flow.
Brady Corp (BRC) has received a notable upgrade within Validea's 'Patient Investor' model, which is based on Warren Buffett's investment principles, with its score increasing from 72% to 79%. This places the mid-cap company just below the 80% threshold that the strategy uses to signal initial investment interest. The score improvement is attributed to the firm's underlying fundamentals and current valuation. Critically, BRC passed all nine of the model's rigorous tests, demonstrating predictable earnings, manageable debt service, and strong returns on both equity and total capital. The analysis also positively flags the company's free cash flow generation, effective use of retained earnings, and a consistent share repurchase program, indicating a shareholder-friendly capital allocation policy. The passing grades for 'Initial Rate of Return' and 'Expected Return' suggest that, according to this model, BRC's stock is trading at a reasonable price relative to its fundamental strength.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.65
Ticker Sentiment